flomics.bsky.social
@flomics.bsky.social
Liquid biopsy & transcriptomics for biomarker discovery in cancer and beyond. Robust science, reproducibility & RNA-based diagnostics. 🌐 https://flomics.com
🫁 This Friday is World Lung Cancer Day.
At Flomics, we’re developing RNA-based liquid biopsy tools for early, non-invasive detection.
Every dataset matters. Every life matters.
🎗️ To patients, families & researchers: we see you, we work for you.
#WorldLungCancerDay #EarlyDetection #Flomics
July 30, 2025 at 12:40 PM
No endless waiting ⏳
No invasive procedures 💉
Just fast, accurate, and early answers ⚡

Our goal: detect cancer early through a simple blood test — powered by RNA🩸🧬

Behind every breakthrough is a dedicated team 🧬💻🧪

#LiquidBiopsy #RNA #CancerDetection #Bioinformatics #PrecisionMedicine #TeamScience
July 22, 2025 at 9:27 AM
And now for a not-so-humble brag…
We were thrilled when the analysis revealed our own in-house Flomics libraries, using a rigorous double-DNase digestion protocol, ranked as the highest-quality dataset among all whole-cfRNA-Seq methods! 🎉💪
July 15, 2025 at 8:39 AM
Beware of confounders!
We highlight how technical factors are often mixed with patient phenotype, making true, generalizable biomarker discovery a huge challenge.
July 15, 2025 at 8:39 AM
Protocols are not created equal. We show how different workflows give you vastly different pictures of the transcriptome.
July 15, 2025 at 8:39 AM
This technical noise is loud!
The variation we found is greater than the biological variation across 29 different human tissues. Let that sink in.
July 15, 2025 at 8:39 AM
It’s the method, not the biology.
We found that inter-lab batch effects, genomic DNA contamination, and library diversity explain the main differences between samples.
July 15, 2025 at 8:39 AM
We had a hunch, so we conducted a massive cross-study analysis of >2,300 samples from 15 studies, plus libraries generated in-house at Flomics. We used a uniform bioinformatics pipeline to see what was really going on.

Results were… illuminating.
July 15, 2025 at 8:39 AM
Beware of confounders!
We highlight how technical factors are often mixed with patient phenotype, making true, generalizable biomarker discovery a huge challenge.
July 15, 2025 at 8:03 AM
Protocols are not created equal.
We show how different workflows give you vastly different pictures of the transcriptome.
July 15, 2025 at 8:03 AM
This technical noise is loud!
The variation we found is greater than the biological variation across 29 different human tissues. Let that sink in.
July 15, 2025 at 8:03 AM
It’s the method, not the biology.
We found that inter-lab batch effects, genomic DNA contamination, and library diversity explain the main differences between samples.
July 15, 2025 at 8:03 AM